Minerva Neurosciences (NERV) Retained Earnings (2013 - 2026)

Minerva Neurosciences has reported Retained Earnings for 14 years, with the latest figure at -$814.2 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 103.99% year-over-year to -$814.2 million; the trailing twelve-month figure through Mar 2026 stood at -$814.2 million (down 103.99% YoY), and the FY2025 full-year result was -$688.8 million, down 74.21% from the prior year.
• Retained Earnings for Q1 2026 stood at -$814.2 million, down from -$688.8 million in the prior quarter.
• The five-year high for Retained Earnings was -$344.5 million in Q1 2022, with the low at -$814.2 million in Q1 2026.
• Historically, Retained Earnings has averaged -$428.1 million across 5 years, with a median of -$395.4 million in 2024.
• Annual changes were most pronounced in 2025 — Retained Earnings climbed 2.71% — and 2026, when it slumped 103.99%.
• Minerva Neurosciences' Retained Earnings stood at -$366.8 million in 2022, then fell by 8.18% to -$396.8 million in 2023, then increased by 0.36% to -$395.4 million in 2024, then plunged by 74.21% to -$688.8 million in 2025, then dropped by 18.21% to -$814.2 million in 2026.
• The last three Retained Earnings figures came in at -$814.2 million (Q1 2026), -$688.8 million (Q4 2025), and -$405.1 million (Q3 2025), per Business Quant data.